Invitae Corp (NVTA) |
|
45.26 -0.75 (-1.63%)
|
10-24 14:12 |
|
Open: |
46 |
Pre. Close: |
46.01 |
|
High:
|
46.31 |
Low:
|
44.9 |
|
Volume:
|
1,342,419 |
Market Cap:
|
8,072M |
|
|
|
|
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. The company is headquartered in San Francisco, California and currently employs 1,100 full-time employees. As of December 31, 2016, the Company's products consisted of assays totaling over 1,100 genes that could be used for multiple indications, including hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders and other hereditary conditions. The firm offers panels for a range of hereditary conditions in cancer, cardiology, neuromuscular, pediatric and rare diseases. The firm focuses on genetic testing, genome network and genome management. The firm offers full gene sequencing and deletion/duplication analysis as a standard for all of its tests. The firm holds interests in AltaVoice, a patient-centered data company. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
46.369 - 46.594 |
46.594 - 46.816 |
|
Low:
|
44.24 - 44.521 |
44.521 - 44.798 |
|
Close:
|
44.738 - 45.185 |
45.185 - 45.625 |
|
Technical analysis |
as of: 2020-10-23 4:47:22 PM |
|
Overall:
|
 |
| Stoxline posted a SELL today, same as yesterday. Downward movement continues. |
| Target: |
Six months: 56.75 One year: 64.68 |
| Support: |
Support1: 37.59 Support2: 31.27 |
| Resistance: |
Resistance1: 48.58 Resistance2: 55.38 |
| Pivot: |
48.52  |
| Moving Average: |
MA(5): 46.19  MA(20): 47.29
MA(100): 34.04 MA(250): 24.00 |
| MACD: |
MACD(12,26): 1.67 Signal(9): 2.65 |
| Stochastic oscillator: |
%K(14,3): 19.18 %D(3): 26.32 |
| RSI: |
RSI(14): 50.47 |
| 52-week: |
High: 55.38 Low: 7.41 Change(%): 155.3 |
| Average Vol(K): |
3-Month: 275545 10-Days: 264127 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.NVTA has closed above bottom band by 21.2%. Bollinger Bands are 13.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
Fri, 23 Oct 2020
Invitae Corporation (NVTA) Volatility Hits 5.76% – Here’s What A Good Investor Should Do - Stocks Register
Tue, 20 Oct 2020
Think You Need A Good Stock? Look At This Invitae Corporation (NYSE:NVTA) Analysis - Stocks Register
Tue, 13 Oct 2020
Invitae Corporation (NYSE:NVTA) Share Price Tumble Recently, But Trouble May Still Be Afoot - Stocks Register
Fri, 09 Oct 2020
Fresh Data-Based Insight On Invitae Corporation (NVTA) - Stocks Register
Thu, 08 Oct 2020
InVitae Corp to Post FY2021 Earnings of ($1.68) Per Share, Oppenheimer Forecasts (NYSE:NVTA) - MarketBeat
Wed, 07 Oct 2020
Are Options Traders Betting on a Big Move in Invitae (NVTA) Stock? - Yahoo Finance
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
 |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Underperform |
Price to Earnings: |
Underperform |
| Return on Equity: |
Underperform |
Debt to Equity: |
Outperform |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. (M) |
178 |
| Shares Float (M) |
106 |
|
% Held by Insiders
|
3.34 |
|
% Held by Institutions
|
76.77 |
|
Shares Short (K)
|
21,530 |
|
Shares Short P. Month (K)
|
20,170 |
Stock Financials |
|
EPS
|
-4.020 |
|
EPS Est This Year
|
-2.350 |
|
EPS Est Next Year
|
-1.330 |
|
Book Value (p.s.)
|
3.540 |
|
Profit Margin
|
-180.31 |
|
Operating Margin
|
-148.52 |
|
Return on Assets (ttm)
|
-29.4 |
|
Return on Equity (ttm)
|
-104.4 |
|
Qtrly Rev. Growth
|
-13.6 |
|
Gross Profit (p.s.)
|
0.554 |
|
Sales Per Share
|
1.308 |
|
EBITDA (p.s.)
|
-1.808 |
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-207 |
|
Levered Free Cash Flow (M)
|
0 |
Stock Valuations |
|
PE Ratio
|
-11.26 |
|
PEG Ratio
|
|
|
Price to Book value
|
12.79 |
|
Price to Sales
|
34.61 |
|
Price to Cash Flow
|
-39.05 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
7 Binary Options
|
|
Your Ad Here
|
|
